Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Myssiorek

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
American Journal of Cancer Research|February 18, 2016
Metformin inhibits salivary adenocarcinoma growth through cell cycle arrest and apoptosisYuqi Guo, Tao Yu, Jian Yang, et al.
Head & Neck|January 11, 2020
Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancerBenjamin R Roman, Shivangi Lohia, Nandita Mitra, et al.
Oral Oncology|April 6, 2004
Paragangliomas of the head and neckPhillip K Pellitteri, Alessandra Rinaldo, David Myssiorek, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Guideline familiarity predicts variation in self-reported use of routine surveillance PET/CT by physicians who treat head and neck cancerBenjamin R Roman, Snehal G Patel, Marilene B Wang, et al.
The American Journal of Surgical Pathology|April 24, 2010
Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinomaMargaret Brandwein-Gensler, Richard V Smith, Beverly Wang, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
American Journal of Cancer Research|February 18, 2016
Metformin inhibits salivary adenocarcinoma growth through cell cycle arrest and apoptosisYuqi Guo, Tao Yu, Jian Yang, et al.
Head & Neck|January 11, 2020
Perceived value drives use of routine asymptomatic surveillance PET/CT by physicians who treat head and neck cancerBenjamin R Roman, Shivangi Lohia, Nandita Mitra, et al.
Oral Oncology|April 6, 2004
Paragangliomas of the head and neckPhillip K Pellitteri, Alessandra Rinaldo, David Myssiorek, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 14, 2015
Guideline familiarity predicts variation in self-reported use of routine surveillance PET/CT by physicians who treat head and neck cancerBenjamin R Roman, Snehal G Patel, Marilene B Wang, et al.
The American Journal of Surgical Pathology|April 24, 2010
Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinomaMargaret Brandwein-Gensler, Richard V Smith, Beverly Wang, et al.
Pageof 4